Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diagnostic approach in diffuse infiltrative lung diseases].

D Valeyre1, M Brauner, J Cadranel

  • 1Service de pneumologie, Fédération des maladies respiratoires et thoraciques de l'adulte CHU Avicenne et UPRES EA 2363 UFR SMBH 93009 Bobigny. valeyre@avc.ap-hop-paris.fr

La Revue Du Praticien
|January 11, 2001
PubMed
Summary

Infiltrative lung diseases (ILD) encompass over 130 conditions, requiring differentiation between chronic and acute forms. Diagnosis involves clinical, radiological, and further investigations to identify specific causes and guide treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 "DICIPLE" Phase III Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

AFSOS-SFRO Guidelines on Radiation-Induced Lung Injury.

Clinical lung cancer·2025
Same author

Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis.

Pulmonology·2024
Same author

[Severe hemoptysis in the onco-hematology patient].

Revue des maladies respiratoires·2023

Area of Science:

  • Pulmonology
  • Radiology
  • Pathology

Background:

  • Infiltrative lung diseases (ILD) comprise a heterogeneous group of over 130 distinct conditions.
  • Differentiating between chronic and acute ILD forms is crucial for appropriate management.
  • Identifying known versus unknown causes within each ILD category is essential for individualized patient care.

Purpose of the Study:

  • To outline the diagnostic approach for differentiating chronic and acute infiltrative lung diseases.
  • To highlight the key diagnostic signs and investigations for ILD.
  • To categorize common causes of both chronic and acute ILD.

Main Methods:

  • Initial assessment relies on chest X-rays and pulmonary function tests to detect diffuse pulmonary opacities.
  • Diagnosis of chronic ILD integrates epidemiologic data, patient history, and radiological findings (including CT scans).

Related Experiment Videos

  • Further investigations like blood tests, endoscopy, bronchoalveolar lavage, and lung biopsy are employed for definitive diagnosis.

    • Main Results:

    • Radiological and clinical findings can establish a high-probability diagnosis in at least 60% of chronic ILD cases.
    • Common chronic ILDs include sarcoidosis, idiopathic pulmonary fibrosis, and connective tissue disease-associated ILD.
    • Acute ILDs, characterized by edema or alveolitis, require urgent symptomatic treatment and include conditions like cardiogenic edema and acute eosinophilic pneumonia.

    Conclusions:

    • A systematic diagnostic strategy, combining initial screening with targeted investigations, is vital for managing diverse ILDs.
    • Accurate differentiation between acute and chronic ILD forms, and their specific etiologies, dictates therapeutic interventions.
    • Prompt diagnosis and management are critical, especially for acute ILD presentations.